Purple Biotech (PPBT) Cash from Operations (2017 - 2026)
Purple Biotech (PPBT) reported Cash from Operations of 3121000.0 for Q1 2026, down 57.79% year-over-year from 7393219.16 in Q1 2025, and down 192.5% quarter-over-quarter from 1067000.0 in Q4 2025.
Purple Biotech (PPBT) Cash from Operations (2017 - 2026) Analysis & Trends
Purple Biotech (PPBT) has 10 years of Cash from Operations data on file, last reported at 3121000.0 in Q1 2026.
- Cash from Operations for Q1 2026 came in at 3121000.0, down 57.79% year-over-year; the trailing twelve-month figure through Mar 2026 was 6799000.0 (up 39.63% YoY), and the FY2025 annual result was 5656000.0, up 60.63% from the prior year.
- Cash from Operations slipped to 3121000.0 in Q1 2026 per PPBT's latest filing, from 1067000.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 1067000.0 in Q3 2025 and troughed at 6064000.0 in Q1 2023.
- A 5-year average of 3517882.35 and a median of 3656000.0 in 2023 frame the typical range for Cash from Operations.
- The sharpest annual moves came in 2025 and 2026: Cash from Operations soared 67.62% in 2025, then tumbled 57.79% in 2026.
- A 5-year view of Cash from Operations shows it stood at 4214000.0 in 2022, then retreated by 18.22% to 4982000.0 in 2023, then soared by 59.57% to 2014000.0 in 2024, then soared by 47.02% to 1067000.0 in 2025, then plunged by 192.5% to 3121000.0 in 2026.
- Business Quant data shows PPBT's Cash from Operations at 3121000.0 in Q1 2026, 1067000.0 in Q4 2025, and 1067000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -2.49 Mn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 1.43 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Purple Biotech | 242.86 Mn | 236.43 Mn | - | -3.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.12 Mn |
| Mar 31, 2026 | -3.12 Mn |
| Dec 31, 2025 | -1.07 Mn |
| Dec 31, 2025 | -1.07 Mn |
| Sep 30, 2025 | -1.07 Mn |
| Sep 30, 2025 | -1.07 Mn |
| Jun 30, 2025 | -1.54 Mn |
| Jun 30, 2025 | -1.54 Mn |
| Mar 31, 2025 | -1.98 Mn |
| Mar 31, 2025 | -1.98 Mn |
| Dec 31, 2024 | -2.01 Mn |
| Dec 31, 2024 | -2.01 Mn |
| Sep 30, 2024 | -3.30 Mn |
| Sep 30, 2024 | -3.30 Mn |
| Jun 30, 2024 | -3.98 Mn |
| Jun 30, 2024 | -3.98 Mn |
| Mar 31, 2024 | -5.08 Mn |
| Mar 31, 2024 | -5.08 Mn |
| Dec 31, 2023 | -4.98 Mn |
| Dec 31, 2023 | -4.98 Mn |